Skip to content

RapidFor™

by Vitrosens Biotechnology Inc. 280 variants

Ref VMPO84Model VMPO84ED

RapidFor (VMPO84) is an in vitro diagnostic device (EU IVDR general IVD; EU IVDR Class C; EMDN category cancer antigen 15-3) made by Vitrosens Biotechnology Inc., registered in EUDAMED on 31 Aug 2026 (Basic UDI-DI B-08684595035375), active as of 24 Oct 2026.

Active European Union

CE IVDR CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR NumberB-08684595035375 Basic UDI-DI 08684595035375UDI-DIDate31 Aug 2026RegisteredStatusActive
European UnionCE/IVDD NumberB-08684595035375 Basic UDI-DI 08684595035375UDI-DIDate31 Aug 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR, CE/IVDD Active

Specification

EUDAMED

Device name
Ca 15-3 (Fia)
Model / reference
VMPO84ED, VMPO84
Primary DI / UDI-DI
08684595035375
Basic UDI-DI
B-08684595035375, 868459503VMPO84EPR7
EMDN code
W0102030102 Cancer antigen 15-3
Device class
Class IVD General
Class C
EU registration type
Legacy device (under a directive)
Standard device
EU market of registration
Türkiye

Manufacturer details

EUDAMED SRN
TR-MF-000026452

Similar devices in this category

Other devices filed under CANCER ANTIGEN 15-3.

Other devices from Vitrosens Biotechnology Inc.

See all devices from Vitrosens Biotechnology Inc. →

Properties

  • Reagent
  • IVD kit
  • Professional testing
Other properties (10, all answered No)